Progesterone receptor antagonists and prostaglandins in human fertility regulation: a clinical review
review
OA: closed
CC0
Abstract
Progesterone receptor antagonists have been developed by substitutions at the 11-beta and 17 side-chain positions of the progestagen norethisterone. The most studied progesterone receptor antagonists are mifepristone (Mifegyne; Roussel-UCLAF; RU486) and ZK98734 and ZK98299 (Schering AG). These compounds bind avidly to the progesterone receptor and glucocorticoid receptor but have essentially no binding to the mineralocortocoid, oestrogen or androgen receptors. Mifepristone also binds avidly to albumin, resulting in a half-life of approximately 24 h after oral administration. Progesterone receptor antagonists can induce menstruation by a direct action upon the endometrium. They have also been shown to exert weak progesterone agonist actions in certain circumstances and to modulate pituitary hormone secretion by antagonizing the feedback actions of progesterone. Moreover, they release prostaglandin F2 alpha and E2 from human endometrium or early pregnancy decidua and reduce the metabolism of these eicosanoids. Clinically, progesterone receptor antagonists have been used in trials of menstrual regulation, abortion and induction of labour, and during treatment of breast or ovarian cancer, some forms of hypertension and meningioma. Progesterone receptor antagonists have been administered to approximately 70,000 women in 18 countries as medical abortifacients. They have been proven, especially when combined with prostaglandin analogues, to be as effective as surgical methods of termination of pregnancy. Progesterone receptor antagonists have focussed international attention on menstrual regulation, abortion and the rights of women to regulate their fertility.
My notes (saved in your browser only)
Citation neighborhood (no data yet)
We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.
References (30)
- W20996512 via openalex
- W634274073 via openalex
- W1488678565 via openalex
- W1586198177 via openalex
- W1618813839 via openalex
- W1964022820 via openalex
- W1964268514 via openalex
- W1979266157 via openalex
- W1982627872 via openalex
- W1984562516 via openalex
- W1989541713 via openalex
- W1995778516 via openalex
- W1995832802 via openalex
- W2000018061 via openalex
- W2033524269 via openalex
- W2037113863 via openalex
- W2044785965 via openalex
- W2049211310 via openalex
- W2054254905 via openalex
- W2063501989 via openalex
- W2068921569 via openalex
- W2084904002 via openalex
- W2085139454 via openalex
- W2086333214 via openalex
- W2102874613 via openalex
- W2107425091 via openalex
- W2157376240 via openalex
- W2412441539 via openalex
- W2417930906 via openalex
- W4285719527 via openalex
Source provenance
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- unpaywall
- last seen: 2026-07-13T06:45:44.122212+00:00
License: CC0
· commercial use OK